Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Heidegger Mateos-Toledo"'
Autor:
Heidegger Mateos-Toledo, Jonathan Saúl Castillo-Pedroza, Jorge Rojas-Serrano, Kelly Castillo-Castillo, Óscar Rodríguez-Barreto, Miguel Gaxiola, M. Mejia-Avila, Ivette Buendía-Roldán, José Guillermo Mejía-Hurtado, Andrea Estrada, Moisés Selman
Publikováno v:
Archivos de Bronconeumología. 56:163-169
Background Chronic hypersensitivity pneumonitis (cHP) represents a severe lung disease often evolving to fibrosis with the subsequent destruction of the lung parenchyma. There are no approved therapies with confirmed efficacy to deal with this diseas
Autor:
Andrea Estrada-Garrido, Jorge Rojas-Serrano, Mayra Mejía, Angel Emmanuel Vega-Sanchez, Heidegger Mateos-Toledo, Pedro Abisay Rivera-Matias, Diego Alexis García-Estudillo, Jhonathan Saul Castillo-Pedroza
Publikováno v:
Imaging.
Autor:
Angel Emmanuel Vega-Sanchez, M. Mejia-Avila, Diego Alexis García Estudillo, Heidegger Mateos-Toledo, Jonathan Saúl Castillo-Pedroza, Jorge Rojas-Serrano, Andrea Estrada-Garrido
Publikováno v:
Respiratory infections and bronchiectasis.
Autor:
Jorge Rojas-Serrano, Mayra Mejía, Pedro A. Rivera-Matias, Denisse Herrera-Bringas, Diana I. Pérez-Román, Renzo Pérez-Dorame, Heidegger Mateos-Toledo
Publikováno v:
Clinical rheumatology. 41(6)
We hypothesized that RA disease activity might be associated with the survival of RA-ILD patients. To evaluate this possibility, we analyzed data on disease activity during follow-up in an RA-ILD cohort and compared disease activity between surviving
Autor:
Montserrat I González-Pérez, Heidegger Mateos-Toledo, Ivette Buendía-Roldán, José Guillermo Mejía-Hurtado, Mayra Mejía, Ramcés Falfán-Valencia, Diana Isabel Perez-Roman, Jorge Rojas-Serrano
Publikováno v:
The Journal of Rheumatology. 47:415-423
Objective.To describe the evolution of the pulmonary function in patients with interstitial lung disease (ILD) who are positive for at least 1 of the antisynthetase antibodies (ASAB) after medical treatment, and to compare whether the evolution of pu
Autor:
María Laura Alberti, Martín Eduardo Fernández, Fabian Caro, Jorge Rojas-Serrano, Mayra Edith Mejía, Francisco Paulin, Heidegger Mateos Toledo
Publikováno v:
Reumatología Clínica. 14:75-80
Resumen Objetivos Agrupar a los pacientes con enfermedad pulmonar intersticial (EPI) asociada a enfermedad indiferenciada del tejido conectivo (EITC) segun la presencia o no de ciertas manifestaciones clinicas o inmunologicas, esperando encontrar dif
Autor:
María Laura Alberti, Martín Eduardo Fernández, Mayra Edith Mejía, Fabian Caro, Francisco Paulin, Jorge Rojas-Serrano, Heidegger Mateos Toledo
Publikováno v:
Reumatología Clínica (English Edition). 14:75-80
To identify clinical or immunological features in patients with undifferentiated connective tissue disease (UCTD) associated interstitial lung disease (ILD), in order to group them and recognize different functional and high resolution computed tomog
Autor:
Luis Torre-Bouscoulet, Laura Gochicoa-Rangel, Mayra Edith Mejía Avila, Julia Sánchez Hernández, José Luis Miguel Reyes, Selene Guerrero Zúñiga, Heidegger Mateos Toledo, Moisés Selman
Publikováno v:
Respirology. 22:1637-1642
Background and objective Lung biopsies from patients with hypersensitivity pneumonitis (HP) have demonstrated small airway (SA) involvement, but there is no information concerning SA function in HP, and it is unknown whether pharmacological treatment
Autor:
Renzo Pérez-Dórame, Heidegger Mateos-Toledo, Denisse Herrera-Bringas, Jorge Rojas-Serrano, Mayra Mejía, Diana Isabel Perez-Roman
Publikováno v:
Clinical Rheumatology. 36:1493-1500
Interstitial lung disease (ILD) is a severe rheumatoid arthritis (RA) manifestation. The worst survival has been associated with usual interstitial pneumonia (UIP) definitive pattern in high-resolution chest tomography (HRCT) scans. Moreover, the use
Autor:
Mayra Mejía, Heidegger Mateos-Toledo, Hermes Rivero, José E. Figueroa, Denisse Herrera-Bringas, Diana Isabel Perez-Roman, Jorge Rojas-Serrano, Pedro Castorena-García
Publikováno v:
Respiratory Medicine. 123:79-86
Objective to describe the clinical manifestations and survival of patients with ILD and myositis-specific and associated autoantibodies, and to evaluate the performance of the new ATS/ERS classification criteria for IPAF. Patients and methods Patient